Approaching HER2 Testing in Breast Cancer

preview_player
Показать описание
New guideline recommendations for HER2 testing in breast cancer, and the importance of defining heterogeneity.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Guidelines and Approaches 0:08:59

Guidelines and Approaches to HER2 Testing for Breast Cancer

Approaching HER2 Testing 0:08:29

Approaching HER2 Testing in Breast Cancer

HER2 In Breast 0:46:51

HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches

HER2 Assessment in 0:01:53

HER2 Assessment in Breast Cancer

Ask Your Oncologist 0:00:51

Ask Your Oncologist About HER2 Testing... Again

HER2 Testing Explained: 0:08:09

HER2 Testing Explained: What’s New in 2024?

HER2 IHC Interpretation 0:35:58

HER2 IHC Interpretation Guide (Examples and Challenging Scenarios)

HER2 Assessment in 0:01:53

HER2 Assessment in Breast Cancer

HER2 in Cancer 0:03:09

HER2 in Cancer

Case 1: Guidelines 0:05:33

Case 1: Guidelines for HER2 Testing in Breast Cancer

Testing for HER2 0:05:48

Testing for HER2 Expression in Breast Cancer Patients

Recommendations for HER2 0:04:19

Recommendations for HER2 Testing in Breast Cancer

HER2 Testing in 0:55:51

HER2 Testing in Breast Cancer: Improving IHC Performance

Updates in HER2 0:36:00

Updates in HER2 Testing in Breast Cancer

HER2 Testing in 0:08:12

HER2 Testing in Metastatic Breast Cancer

Dr. Tolaney on 0:01:39

Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast Cancer

HER2 Low Breast 0:25:20

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference

How to Improve 1:03:11

How to Improve HER2 testing Accuracy: Incorporating the 2018 ASCO/CAP Focused Update

ER/PR Tests | 0:01:23

ER/PR Tests | Estrogen Receptor, Progesterone Receptor Tests | ER/PR Tests For breast cancer |

Case 1: When 0:02:07

Case 1: When to Use FISH Testing in Breast Cancer

A New View 1:25:22

A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer

A Guide for 1:25:12

A Guide for Selection, Sequencing, and Optimal Use of HER2-Targeted Therapies in HER2+ Breast Cancer

Approach to Breast 0:20:01

Approach to Breast Masses/Cancer - CRASH! Medical Review Series

Biomarker Testing for 1:27:49

Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors